Brian Jeffrey Bearie, | |
2101 N Waterman Ave, San Bernardino, CA 92404-4836 | |
(909) 881-4357 | |
Not Available |
Full Name | Brian Jeffrey Bearie |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 25 Years |
Location | 2101 N Waterman Ave, San Bernardino, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386754216 | NPI | - | NPPES |
00A730110 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | A73011 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Bernardine Medical Center | San bernardino, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Southern California Emergency Medicine | 8628128196 | 35 |
News Archive
Senomyx, Inc. has announced the issuance by the U.S. Patent and Trademark Office of U.S. Patent No. 7,241, 880, "T1R Taste Receptors and Genes Encoding Same."
Weight-loss program participants who had a brief, monthly personal contact intervention - most often a 10-15 minute phone conversation - regained less weight than participants who were in a Web-based intervention or self-directed program, according to a study in the March 12 issue of JAMA, the Journal of the American Medical Association.
Girls treated for Hodgkin's disease during adolescence acquire a considerable risk of developing breast cancer, as shown by an observational study published in the current issue of Deutsches Ärzteblatt International.
A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pathway - a series of interaction among proteins - involved in the development of diabetes. Furthermore, they have found that a drug already approved for use in humans can regulate the pathway.
› Verified 2 days ago
Entity Name | Southern California Emergency Medicine |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1639314255 PECOS PAC ID: 8628128196 Enrollment ID: O20090604000499 |
News Archive
Senomyx, Inc. has announced the issuance by the U.S. Patent and Trademark Office of U.S. Patent No. 7,241, 880, "T1R Taste Receptors and Genes Encoding Same."
Weight-loss program participants who had a brief, monthly personal contact intervention - most often a 10-15 minute phone conversation - regained less weight than participants who were in a Web-based intervention or self-directed program, according to a study in the March 12 issue of JAMA, the Journal of the American Medical Association.
Girls treated for Hodgkin's disease during adolescence acquire a considerable risk of developing breast cancer, as shown by an observational study published in the current issue of Deutsches Ärzteblatt International.
A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pathway - a series of interaction among proteins - involved in the development of diabetes. Furthermore, they have found that a drug already approved for use in humans can regulate the pathway.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Brian Jeffrey Bearie, 1407 Foothill Blvd # 14, La Verne, CA 91750-3451 Ph: (909) 596-6349 | Brian Jeffrey Bearie, 2101 N Waterman Ave, San Bernardino, CA 92404-4836 Ph: (909) 881-4357 |
News Archive
Senomyx, Inc. has announced the issuance by the U.S. Patent and Trademark Office of U.S. Patent No. 7,241, 880, "T1R Taste Receptors and Genes Encoding Same."
Weight-loss program participants who had a brief, monthly personal contact intervention - most often a 10-15 minute phone conversation - regained less weight than participants who were in a Web-based intervention or self-directed program, according to a study in the March 12 issue of JAMA, the Journal of the American Medical Association.
Girls treated for Hodgkin's disease during adolescence acquire a considerable risk of developing breast cancer, as shown by an observational study published in the current issue of Deutsches Ärzteblatt International.
A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pathway - a series of interaction among proteins - involved in the development of diabetes. Furthermore, they have found that a drug already approved for use in humans can regulate the pathway.
› Verified 2 days ago
David D. Tito, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2101 N Waterman Ave, San Bernardino, CA 92404 Phone: 909-883-8711 | |
Dr. Julie Kay Kasarjian, M.D., PH.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 N D St, San Bernardino, CA 92410 Phone: 909-381-3774 | |
Judy Charyln Patterson, M.D Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2101 N Waterman Ave, San Bernardino, CA 92404 Phone: 909-881-4357 | |
Allyson Entwistle, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2101 N Waterman Ave, San Bernardino, CA 92404 Phone: 909-883-8711 | |
Micah Leigh Wittler, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2101 N Waterman Ave, San Bernardino, CA 92404 Phone: 909-806-1529 | |
Sabina Berkeley Moore-cohen, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1805 Medical Center Dr, Medical Staff Office, San Bernardino, CA 92411 Phone: 909-806-1598 |